Tricia Cottrell
Tricia Cottrell
Verified email at
Cited by
Cited by
Neoadjuvant PD-1 blockade in resectable lung cancer
PM Forde, JE Chaft, KN Smith, V Anagnostou, TR Cottrell, MD Hellmann, ...
New England Journal of Medicine 378 (21), 1976-1986, 2018
Implications of the tumor immune microenvironment for staging and therapeutics
JM Taube, J Galon, LM Sholl, SJ Rodig, TR Cottrell, NA Giraldo, AS Baras, ...
Modern Pathology 31 (2), 214-234, 2018
RNA Interference in the Pathogenic Fungus Cryptococcus neoformans
H Liu, TR Cottrell, LM Pierini, WE Goldman, TL Doering
Genetics 160 (2), 463-470, 2002
Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC)
TR Cottrell, ED Thompson, PM Forde, JE Stein, AS Duffield, ...
Annals of Oncology 29 (8), 1853-1860, 2018
Dynamics of Tumor and Immune Responses during Immune Checkpoint Blockade in Non–Small Cell Lung CancerDynamics of ctDNA and TCR Repertoire during Anti-PD1
V Anagnostou, PM Forde, JR White, N Niknafs, C Hruban, J Naidoo, ...
Cancer research 79 (6), 1214-1225, 2019
Association of PD-1/PD-L axis expression with cytolytic activity, mutational load, and prognosis in melanoma and other solid tumors
L Danilova, H Wang, J Sunshine, GJ Kaunitz, TR Cottrell, H Xu, ...
Proceedings of the National Academy of Sciences 113 (48), E7769-E7777, 2016
Melanoma subtypes demonstrate distinct PD-L1 expression profiles
GJ Kaunitz, TR Cottrell, M Lilo, V Muthappan, J Esandrio, S Berry, H Xu, ...
Laboratory investigation 97 (9), 1063-1071, 2017
Silence of the strands: RNA interference in eukaryotic pathogens
TR Cottrell, TL Doering
TRENDS in Microbiology 11 (1), 37-43, 2003
PD-L1 Expression in Melanoma: A Quantitative Immunohistochemical Antibody ComparisonMeasurement of PD-L1 in Melanoma
JC Sunshine, PL Nguyen, GJ Kaunitz, TR Cottrell, S Berry, J Esandrio, ...
Clinical Cancer Research 23 (16), 4938-4944, 2017
Multidimensional, quantitative assessment of PD-1/PD-L1 expression in patients with Merkel cell carcinoma and association with response to pembrolizumab
NA Giraldo, P Nguyen, EL Engle, GJ Kaunitz, TR Cottrell, S Berry, ...
Journal for immunotherapy of cancer 6 (1), 1-11, 2018
PD-L1 and Emerging Biomarkers in PD-1/PD-L1 Blockade Therapy
T Cottrell, JM Taube
Cancer journal (Sudbury, Mass.) 24 (1), 41, 2018
Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers
JX Caushi, J Zhang, Z Ji, A Vaghasia, B Zhang, EHC Hsiue, BJ Mog, ...
Nature 596 (7870), 126-132, 2021
Transcriptional Mechanisms of Resistance to Anti–PD-1 TherapyTranscriptional Mechanisms of Resistance to Anti–PD-1
ML Ascierto, A Makohon-Moore, EJ Lipson, JM Taube, TL McMiller, ...
Clinical cancer research 23 (12), 3168-3180, 2017
Compartmental Analysis of T-cell Clonal Dynamics as a Function of Pathologic Response to Neoadjuvant PD-1 Blockade in Resectable Non–Small Cell Lung CancerT-cell Dynamics …
J Zhang, Z Ji, JX Caushi, M El Asmar, V Anagnostou, TR Cottrell, ...
Clinical Cancer Research 26 (6), 1327-1337, 2020
Pan-tumor pathologic scoring of response to PD-(L) 1 blockade
JE Stein, EJ Lipson, TR Cottrell, PM Forde, RA Anders, ...
Clinical Cancer Research 26 (3), 545-551, 2020
Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer
JE Reuss, V Anagnostou, TR Cottrell, KN Smith, F Verde, M Zahurak, ...
Journal for immunotherapy of cancer 8 (2), 2020
Association of HIV status with local immune response to anal squamous cell carcinoma: implications for immunotherapy
EL Yanik, GJ Kaunitz, TR Cottrell, F Succaria, TL McMiller, ML Ascierto, ...
JAMA oncology 3 (7), 974-978, 2017
Analysis of multispectral imaging with the AstroPath platform informs efficacy of PD-1 blockade
S Berry, NA Giraldo, BF Green, TR Cottrell, JE Stein, EL Engle, H Xu, ...
Science 372 (6547), eaba2609, 2021
The Pathogenic Fungus Cryptococcus neoformans Expresses Two Functional GDP-Mannose Transporters with Distinct Expression Patterns and Roles in Capsule …
TR Cottrell, CL Griffith, H Liu, AA Nenninger, TL Doering
Eukaryotic Cell 6 (5), 776-785, 2007
The degree of skin involvement identifies distinct lung disease outcomes and survival in systemic sclerosis
TR Cottrell, RA Wise, FM Wigley, F Boin
Annals of the rheumatic diseases 73 (6), 1060-1066, 2014
The system can't perform the operation now. Try again later.
Articles 1–20